Stock IdeasStrong Buy Stocks

Strong Buy Stocks from Top Wall Street Analysts

Latest stocks with a Strong Buy rating from the top performing 25% of analysts tracked by WallStreetZen

Jefferies's Brian Tanquilut raised their price target on Hca Healthcare (NYSE: HCA) by 8.2% from $485 to $525 on 2025/10/28. The analyst maintained their Strong Buy rating on the stock.

HCA Healthcare reported its Q3 2025 earnings.

The company delivered "a good Q3, with a solid EBITDA beat," Tanquilut told readers.

The size of the quarter's beat highlighted how significant the upside could be from other upcoming state-directed payments approvals and made investors overlook the impasse in Congress over health insurance exchange subsidies, the analyst added.

Earnings Report

For Q3 2025, HCA Healthcare reported:

• EPS of $6.96, which beat the Zacks Consensus Estimate of $5.65 and, by 42.6%, Q3 2024’s $5.05.
• Revenue of $19.16B, which beat the Zacks Consensus Estimate by 3.55% and, by 9.6%, Q3 2024’s $17.49B.

For FY 2025, management guided:

• EPS of $27.00 to $28.00.
• Revenue of $75B to $76.5B.

CEO Sam Hazen commented: "Our teams continued to execute our agenda at a high level, and we remain disciplined in our efforts to improve care for our patients by increasing access, investing in advanced technology, and training our people.

"Across many operational measures, including quality and key stakeholders' satisfaction, outcomes were better.”